ClinicalTrials.gov
public full text
Public Domain
Inflammation in Peritoneal Dialysis Patients: Effect of Obesity
end-stage-renal-diseaseinflammationinnate-immunitymacrophagesobesityperitoneal-dialysisrenal-disease
Our study addresses the following research question: What is the role of obesity in modulating inflammation and innate immune function, as well as the overall responsiveness of innate immune cells (such as macrophages, neutrophils, and other peripheral leukocytes) in patients undergoing peritoneal dialysis? The investigators hypothesize that obesity will lead to increased inflammation in patients undergoing peritoneal dialysis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Immune System in Diabetic Kidney Disease#429714
- Chronic Kidney Disease-Associated Defect in Humoral Immune Response Is Driven by Inflammation#643261
- Immune System Related Kidney Disease#253137
- Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients#894559
- Effect of Prebiotics and/or Probiotics on Uremic Toxins and Inflammation Markers in Peritoneal Dialysis Patients#885024
Record · ID 1096469
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive